RT Journal Article
SR Electronic
T1 295 Novel T-cell immunotherapeutics enable the selective generation of more potently cytotoxic CD19 chimeric antigen receptor T-cells (CAR-T cells) from CMV-specific cytotoxic T-cells
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A336
OP A338
DO 10.1136/jitc-2023-SITC2023.0295
VO 11
IS Suppl 1
A1 Rabin, Moriah
A1 Cole, Erin
A1 Garforth, Scott
A1 Zheng, Jian Hua
A1 Almo, Steven
A1 Goldstein, Harris
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A336.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.